Acorn Energy's 15min chart triggered bearish signals with MACD Death Cross and KDJ Death Cross

Acorn Energy's 15-minute chart has triggered a MACD Death Cross, KDJ Death Cross, and Bearish Marubozu at 09/15/2025 11:45. This suggests that the stock price has the potential to continue its downward trajectory, with a shift in momentum towards the downside and a likelihood of further decreases. The current market conditions indicate that sellers are in control, and bearish momentum is likely to persist.

Acorn Energy Inc. (OTCMKTS:ACFN) has experienced a notable decline in its stock price, with technical indicators suggesting a potential downward trajectory. On September 15, 2025, at 11:45, the 15-minute chart of Acorn Energy triggered a MACD Death Cross, KDJ Death Cross, and Bearish Marubozu, indicating a shift in momentum towards the downside Acorn Energy (OTCMKTS:ACFN) Stock Crosses Above 200-Day Moving Average - Here's Why^[1].

The MACD Death Cross occurs when the MACD line crosses below the signal line, signaling a potential reversal of the trend. Similarly, the KDJ Death Cross indicates a bearish momentum when the K line crosses below the D line. The Bearish Marubozu, characterized by a single candle with no shadows, suggests strong bearish momentum.

The current market conditions are dominated by sellers, with the stock price currently trading at $30.14, down from its 200-day moving average of $19.09 Acorn Energy (OTCMKTS:ACFN) Stock Crosses Above 200-Day Moving Average - Here's Why^[1]. The company's market capitalization stands at $75.38 million, and it has a price-to-earnings ratio of 11.29 Acorn Energy (OTCMKTS:ACFN) Stock Crosses Above 200-Day Moving Average - Here's Why^[1].

Analysts have not shown strong enthusiasm for Acorn Energy, with the stock not being among the top recommendations from leading analysts Acorn Energy (OTCMKTS:ACFN) Stock Crosses Above 200-Day Moving Average - Here's Why^[1]. However, investors should monitor the technical indicators and the broader market conditions to make informed decisions.